AD

Anjulata Dubey

Director Director DIN 09772776
DIN 09772776 First appointment Oct 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2022
Shareholding value Locked Premium profile

About Anjulata Dubey

Data last updated:

Anjulata Dubey has 3 years in corporate governance. Formerly with 1 company, such as Sydion Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 09772776
Primary Designation Director
First Appointment 21 Oct 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Sydion Healthcare Private Limited U24290MP2022PTC063181
Director21 Oct 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sydion Healthcare Private Limited
Premium access

Shareholding and investment profile for Anjulata Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjulata Dubey

Anjulata Dubey has 3 years in corporate governance. Formerly with 1 company, such as Sydion Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Anjulata Dubey is associated with 0 companies as a director.

Anjulata Dubey has expertise in Healthcare.

Anjulata Dubey has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available